{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T06:37:54Z","timestamp":1722062274740},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,1,29]],"date-time":"2009-01-29T00:00:00Z","timestamp":1233187200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1007\/s10620-008-0701-4","type":"journal-article","created":{"date-parts":[[2009,1,28]],"date-time":"2009-01-28T17:54:02Z","timestamp":1233165242000},"page":"54-59","source":"Crossref","is-referenced-by-count":24,"title":["Chronic Aspirin Use Suppresses CDH1 Methylation in Human Gastric Mucosa"],"prefix":"10.1007","volume":"55","author":[{"given":"Tomomitsu","family":"Tahara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakatsu","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Yoshioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Okubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoko","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Kamano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Kamiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuo","family":"Nagasaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masami","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Takahama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiro","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomiyasu","family":"Arisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,1,29]]},"reference":[{"key":"701_CR1","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1053\/gast.2000.9561","volume":"119","author":"CJ Hawkey","year":"2000","unstructured":"Hawkey CJ. Non-steroidal anti-inflammatory drug gastropathy. Gastroenterology. 2000;119:521\u2013535. doi: 10.1053\/gast.2000.9561 .","journal-title":"Gastroenterology"},{"key":"701_CR2","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1056\/NEJM199209103271101","volume":"327","author":"MC Allison","year":"1992","unstructured":"Allison MC, Howatson AG, Torrance CJ, Lee FD, Russel RI. Gastrointestinal damage associated with the use of non-steroidal anti-inflammatory drugs. N Engl J Med. 1992;327:749\u2013754.","journal-title":"N Engl J Med"},{"key":"701_CR3","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJM199906173402407","volume":"340","author":"MM Wolf","year":"1999","unstructured":"Wolf MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of non-steroidal anti-inflammatory drugs. N Engl J Med. 1999;340:1888\u20131999. doi: 10.1056\/NEJM199906173402407 .","journal-title":"N Engl J Med"},{"key":"701_CR4","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1053\/sarh.2000.16643","volume":"30","author":"M Rich","year":"2000","unstructured":"Rich M, Scheiman JM. Nonsteroidal anti-inflammatory drug gastropathy at the millennium: mechanisms and prevention. Semin Arthritis Rheum. 2000;30:167\u2013179. doi: 10.1053\/sarh.2000.16643 .","journal-title":"Semin Arthritis Rheum"},{"key":"701_CR5","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/jnci\/94.4.252","volume":"94","author":"MJ Thun","year":"2002","unstructured":"Thun MJ, Henley SJ, Patrono C. Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst. 2002;94:252\u2013266.","journal-title":"J Natl Cancer Inst"},{"key":"701_CR6","first-page":"4399","volume":"48","author":"GA Kune","year":"1988","unstructured":"Kune GA, Kune S, Watson LF. Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study. Cancer Res. 1988;48:4399\u20134404.","journal-title":"Cancer Res"},{"key":"701_CR7","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/jnci\/83.5.355","volume":"83","author":"L Rosenberg","year":"1991","unstructured":"Rosenberg L, Palmer JR, Zauber AG, Warshauer ME, Stolley PD, Shapiro S. A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. J Natl Cancer Inst. 1991;83:355\u2013358. doi: 10.1093\/jnci\/83.5.355 .","journal-title":"J Natl Cancer Inst"},{"key":"701_CR8","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1056\/NEJM199112053252301","volume":"325","author":"MJ Thun","year":"1991","unstructured":"Thun MJ, Namboodiri MM, Heath CW Jr. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med. 1991;325:1593\u20131596.","journal-title":"N Engl J Med"},{"key":"701_CR9","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1056\/NEJM199509073331001","volume":"333","author":"E Giovannucci","year":"1995","unstructured":"Giovannucci E, Egan KM, Hunter DJ, et al. Aspirin and the risk of colorectal cancer in women. N Engl J Med. 1995;333:609\u2013614. doi: 10.1056\/NEJM199509073331001 .","journal-title":"N Engl J Med"},{"key":"701_CR10","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1136\/bmj.320.7250.1642","volume":"320","author":"MJ Langman","year":"2000","unstructured":"Langman MJ, Cheng KK, Gilman EA, Lancashire RJ. Effect of anti-inflammatory drugs on overall risk of common cancer: case control study in general practice research database. BMJ. 2000;320:1642\u20131646. doi: 10.1136\/bmj.320.7250.1642 .","journal-title":"BMJ"},{"issue":"53","key":"701_CR11","first-page":"1322","volume":"15","author":"MJ Thun","year":"1993","unstructured":"Thun MJ, Namboodiri MM, Calle EE, Flanders WD, Heath CW Jr. Aspirin use and risk of fatal cancer. Cancer Res. 1993;15(53):1322\u20131327.","journal-title":"Cancer Res"},{"key":"701_CR12","first-page":"119","volume":"1","author":"PF Coogan","year":"2000","unstructured":"Coogan PF, Rosenberg L, Palmer JR, et al. Nonsteroidal anti-inflammatory drugs and risk of digestive cancers at sites other than the large bowel. Cancer Epidemiol Biomarkers Prev. 2000;1:119\u2013123.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"701_CR13","first-page":"97","volume":"2","author":"DC Farrow","year":"1998","unstructured":"Farrow DC, Vaughan TL, Hansten PD, et al. Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev. 1998;2:97\u2013102.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"701_CR14","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1002\/1097-0142(19951001)76:7<1116::AID-CNCR2820760703>3.0.CO;2-I","volume":"76","author":"EM Funkhouser","year":"1995","unstructured":"Funkhouser EM, Sharp GB. Aspirin and reduced risk of esophageal carcinoma. Cancer. 1995;76:1116\u20131119. doi:10.1002\/1097-0142(19951001)76:7<1116::AID-CNCR2820760703>.0.CO;2-I.","journal-title":"Cancer"},{"issue":"25","key":"701_CR15","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1365-2036.2006.03224.x","volume":"15","author":"HB Yang","year":"2007","unstructured":"Yang HB, Cheng HC, Sheu BS, Hung KH, Liou MF, Wu JJ. Chronic celecoxib users more often show regression of gastric intestinal metaplasia after Helicobacter pylori eradication. Aliment Pharmacol Ther. 2007;15(25):455\u2013461.","journal-title":"Aliment Pharmacol Ther"},{"key":"701_CR16","first-page":"5438","volume":"59","author":"M Toyota","year":"1999","unstructured":"Toyota M, Ahuja N, Suzuki H, et al. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res. 1999;59:5438\u20135442.","journal-title":"Cancer Res"},{"key":"701_CR17","first-page":"2847","volume":"61","author":"GH Kang","year":"2001","unstructured":"Kang GH, Shim YH, Jung HY, Kim WH, Ro JY, Rhyu MG. CpG island methylation in premalignant stages of gastric carcinoma. Cancer Res. 2001;61:2847\u20132851.","journal-title":"Cancer Res"},{"key":"701_CR18","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1136\/gut.52.4.502","volume":"52","author":"AO Chan","year":"2003","unstructured":"Chan AO, Lam SK, Wong BC, et al. Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer. Gut. 2003;52:502\u2013506. doi: 10.1136\/gut.52.4.502 .","journal-title":"Gut"},{"key":"701_CR19","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1349-7006.2003.tb01447.x","volume":"94","author":"T Waki","year":"2003","unstructured":"Waki T, Tamura G, Sato M, Terashima M, Nishizuka S, Motoyama T. Promoter methylation status of DAP-kinase and RUNX3 genes in neoplastic and non-neoplastic gastric epithelia. Cancer Sci. 2003;94:360\u2013364. doi: 10.1111\/j.1349-7006.2003.tb01447.x .","journal-title":"Cancer Sci"},{"key":"701_CR20","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/S0002-9440(10)63511-0","volume":"163","author":"GH Kang","year":"2003","unstructured":"Kang GH, Lee HJ, Hwang KS, Lee S, Kim JH, Kim JS. Aberrant CpG island hypermethylation of chronic gastritis, in relation to aging, gender, intestinal metaplasia, and chronic inflammation. Am J Pathol. 2003;163:1551\u20131556.","journal-title":"Am J Pathol"},{"key":"701_CR21","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/gut.2005.077776","volume":"55","author":"AO Chan","year":"2006","unstructured":"Chan AO, Peng JZ, Lam SK, et al. Eradication of Helicobacter pylori infection reverses E-cadherin promoter hypermethylation. Gut. 2006;55:463\u2013468. doi: 10.1136\/gut.2005.077776 .","journal-title":"Gut"},{"key":"701_CR22","doi-asserted-by":"crossref","unstructured":"Tahara T, Arisawa T, Shibata T, et al. Increased number of methylated CpG islands correlates with Helicobacter pylori infection, histological and serological severity of chronic gastritis. Eur J Gastroenterol Hepatol (in press).","DOI":"10.1097\/MEG.0b013e32830e28b2"},{"key":"701_CR23","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/ijc.2910350206","volume":"35","author":"P Sipponen","year":"1985","unstructured":"Sipponen P, Kekki M, Haapakoski J, Ihamaki T, Siurala M. Gastric cancer risk in chronic gastritis: statistical calculations of cross-sectional data. Int J Cancer. 1985;35:173\u2013177. doi: 10.1002\/ijc.2910350206 .","journal-title":"Int J Cancer"},{"key":"701_CR24","doi-asserted-by":"crossref","first-page":"9821","DOI":"10.1073\/pnas.93.18.9821","volume":"93","author":"JG Herman","year":"1996","unstructured":"Herman JG, Graff JR, My\u00f6h\u00e4nen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA. 1996;93:9821\u20139826. doi: 10.1073\/pnas.93.18.9821 .","journal-title":"Proc Natl Acad Sci USA"},{"key":"701_CR25","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/ng0894-536","volume":"7","author":"JP Issa","year":"1994","unstructured":"Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet. 1994;7:536\u2013540. doi: 10.1038\/ng0894-536 .","journal-title":"Nat Genet"},{"key":"701_CR26","first-page":"5489","volume":"8","author":"N Ahuja","year":"1998","unstructured":"Ahuja N, Li Q, Mohan AL, Baylin SB, Issa JP. Aging and DNA methylation in colorectal mucosa and cancer. Cancer Res. 1998;8:5489\u20135494.","journal-title":"Cancer Res"},{"key":"701_CR27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1040-8428(99)00019-0","volume":"32","author":"JP Issa","year":"1999","unstructured":"Issa JP. Aging, DNA methylation and cancer. Crit Rev Oncol Hematol. 1999;32:31\u201343. doi: 10.1016\/S1040-8428(99)00019-0 .","journal-title":"Crit Rev Oncol Hematol"},{"key":"701_CR28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1023\/A:1025806911782","volume":"23","author":"Y Kondo","year":"2004","unstructured":"Kondo Y, Issa JP. Epigenetic changes in colorectal cancer. Cancer Metastasis Rev. 2004;23:9\u201339. doi: 10.1023\/A:1025806911782 .","journal-title":"Cancer Metastasis Rev"},{"key":"701_CR29","first-page":"3573","volume":"61","author":"PJ Issa","year":"2001","unstructured":"Issa PJ, Ahuja N, Toyota M, Bronner P, Brentnall TA. Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res. 2001;61:3573\u20133577.","journal-title":"Cancer Res"},{"key":"701_CR30","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1158\/1078-0432.CCR-05-2096","volume":"12","author":"T Maekita","year":"2006","unstructured":"Maekita T, Nakazawa K, Mihara M, et al. High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin Cancer Res. 2006;12:989\u2013995.","journal-title":"Clin Cancer Res"},{"key":"701_CR31","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000101775","volume":"75","author":"T Tahara","year":"2007","unstructured":"Tahara T, Arisawa T, Shibata T, et al. Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium. Digestion. 2007;75:54\u201361.","journal-title":"Digestion"},{"key":"701_CR32","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1523-5378.2008.00572.x","volume":"13","author":"M Kaise","year":"2008","unstructured":"Kaise M, Yamasaki T, Yonezawa J, Miwa J, Ohta Y, Tajiri H. CpG island hypermethylation of tumor-suppressor genes in H.\u00a0pylori-infected non-neoplastic gastric mucosa is linked with gastric cancer risk. Helicobacter. 2008;13:35\u201341. doi: 10.1111\/j.1523-5378.2008.00639.x .","journal-title":"Helicobacter"},{"key":"701_CR33","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1158\/1055-9965.EPI-06-0436","volume":"15","author":"T Nakajima","year":"2006","unstructured":"Nakajima T, Maekita T, Oda I, et al. Higher methylation levels in gastric mucosae significantly correlate with higher risk of gastric cancers. Cancer Epidemiol Biomarkers Prev. 2006;15:2317\u20132321. doi: 10.1158\/1055-9965.EPI-06-0436 .","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"701_CR34","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1093\/carcin\/bgh209","volume":"25","author":"MA Pereira","year":"2004","unstructured":"Pereira MA, Tao L, Wang W, et al. Modulation by celecoxib and difluoromethylornithine of the methylation of DNA and the estrogen receptor-alpha gene in rat colon tumors. Carcinogenesis. 2004;25:1917\u20131923. doi: 10.1093\/carcin\/bgh209 .","journal-title":"Carcinogenesis"},{"key":"701_CR35","first-page":"2378","volume":"62","author":"M Velicescu","year":"2002","unstructured":"Velicescu M, Weisenberger DJ, Gonzales FA, Tsai YC, Nguyen CT, Jones PA. Cell division is required for de novo methylation of CpG islands in bladder cancer cells. Cancer Res. 2002;62:2378\u20132384.","journal-title":"Cancer Res"},{"key":"701_CR36","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/sj.onc.1205153","volume":"21","author":"JZ Song","year":"2002","unstructured":"Song JZ, Stirzaker C, Harrison J, Melki JR, Clark SJ. Hypermethylation trigger of the glutathione-S-transferase gene (GSTP1) in prostate cancer cells. Oncogene. 2002;21:1048\u20131061. doi: 10.1038\/sj.onc.1205153 .","journal-title":"Oncogene"},{"key":"701_CR37","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1128\/MCB.24.11.4781-4790.2004","volume":"24","author":"C Smet De","year":"2004","unstructured":"De Smet C, Loriot A, Boon T. Promoter-dependent mechanism leading to selective hypomethylation within the 5\u2032 region of gene MAGE-A1 in tumor cells. Mol Cell Biol. 2004;24:4781\u20134790. doi: 10.1128\/MCB.24.11.4781-4790.2004 .","journal-title":"Mol Cell Biol"},{"key":"701_CR38","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1349-7006.2005.00035.x","volume":"96","author":"T Ushijima","year":"2005","unstructured":"Ushijima T, Okochi-Takada E. Aberrant methylations in cancer cells: where do they come from? Cancer Sci. 2005;96:206\u2013211. doi: 10.1111\/j.1349-7006.2005.00035.x .","journal-title":"Cancer Sci"},{"key":"701_CR39","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1023\/A:1018830408397","volume":"43","author":"GH Zhu","year":"1998","unstructured":"Zhu GH, Yang XL, Lai KC, et al. Nonsteroidal antiinflammatory drugs could reverse Helicobacter pylori-induced apoptosis and proliferation in gastric epithelial cells. Dig Dis Sci. 1998;43:1957\u20131963. doi: 10.1023\/A:1018830408397 .","journal-title":"Dig Dis Sci"},{"key":"701_CR40","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1136\/gut.34.6.748","volume":"34","author":"N Hudson","year":"1993","unstructured":"Hudson N, Balsitis M, Filipowicz F, Hawkey CJ. Effect of Helicobacter pylori colonisation on gastric mucosal eicosanoid synthesis in patients taking non-steroidal anti-inflammatory drugs. Gut. 1993;34:748\u2013751. doi: 10.1136\/gut.34.6.748 .","journal-title":"Gut"},{"key":"701_CR41","first-page":"1276","volume":"57","author":"A Ristim\u00e4ki","year":"1997","unstructured":"Ristim\u00e4ki A, Honkanen N, J\u00e4nk\u00e4l\u00e4 H, Sipponen P, H\u00e4rk\u00f6nen M. Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res. 1997;57:1276\u20131280.","journal-title":"Cancer Res"},{"key":"701_CR42","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/(SICI)1096-9098(199811)69:3<168::AID-JSO9>3.0.CO;2-0","volume":"69","author":"K Uefuji","year":"1998","unstructured":"Uefuji K, Ichikura T, Mochizuki H, Shinomiya N. Expression of cyclooxygenase-2 protein in gastric adenocarcinoma. J Surg Oncol. 1998;69:168\u2013172. doi:10.1002\/(SICI)1096-9098(199811)69:3<168::AID-JSO9>3.0.CO;2-0.","journal-title":"J Surg Oncol"},{"key":"701_CR43","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0002-9440(10)64586-5","volume":"157","author":"JJ Sung","year":"2000","unstructured":"Sung JJ, Leung WK, Go MY, et al. Cyclooxygenase-2 expression in Helicobacter pylori associated premalignant and malignant gastric lesions. Am J Pathol. 2000;157:729\u2013735.","journal-title":"Am J Pathol"},{"key":"701_CR44","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/gut.2003.021477","volume":"53","author":"PJ Hu","year":"2004","unstructured":"Hu PJ, Yu J, Zeng ZR, et al. Chemoprevention of gastric cancer by celecoxib in rats. Gut. 2004;53:195\u2013200. doi: 10.1136\/gut.2003.021477 .","journal-title":"Gut"},{"key":"701_CR45","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrc780","volume":"2","author":"M Karin","year":"2002","unstructured":"Karin M, Cao Y, Greten FR, Li ZW. NF-kappa B in cancer: from innocent bystander to major culprit. Nat Rev Cancer. 2002;2:301\u2013310. doi: 10.1038\/nrc780 .","journal-title":"Nat Rev Cancer"},{"key":"701_CR46","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1044-579X(02)00128-1","volume":"13","author":"A Lin","year":"2003","unstructured":"Lin A, Karin M. NF-kappa B in cancer: a marked target. Semin Cancer Biol. 2003;13:107\u2013114. doi: 10.1016\/S1044-579X(02)00128-1 .","journal-title":"Semin Cancer Biol"},{"key":"701_CR47","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/23948","volume":"396","author":"MJ Yin","year":"1998","unstructured":"Yin MJ, Yamamoto Y, Gaynor RB. The anti-inflammatory agents: aspirin and salicylate inhibit the activity of I (kappa) B kinase-beta. Nature. 1998;396:77\u201380. doi: 10.1038\/23948 .","journal-title":"Nature"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-008-0701-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-008-0701-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-008-0701-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T17:23:07Z","timestamp":1710004987000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-008-0701-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,29]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["701"],"URL":"https:\/\/doi.org\/10.1007\/s10620-008-0701-4","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,29]]}}}